Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Maddocks

Showing results (21-30 of 215) with videos related to

Pageof 22
Sort By:
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|December 28, 2018
Illness Perceptions in Chronic Lymphocytic Leukemia: Testing Leventhal's Self-regulatory ModelTravis D Westbrook, Eleshia J Morrison, Kami J Maddocks, et al.
Transplantation and Cellular Therapy|March 29, 2026
Phase I Trial of Venetoclax and BEAM followed by Autologous Stem Cell Transplant for High-Risk non-Hodgkin LymphomaJoseph E Maakaron, Qiuhong Zhao, Jayalakshmi P Balakrishna, et al.
Haematologica|July 8, 2021
Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib studyPaolo Strati, Sven De Vos, Jia Ruan, et al.
Cancer|December 11, 2019
Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 studyJonathon B Cohen, Lai Wei, Kami J Maddocks, et al.
British Journal of Haematology|December 2, 2017
A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factorKerry A Rogers, Ying Huang, Amy S Ruppert, et al.
Haematologica|May 17, 2020
Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemiaNyla A Heerema, Natarajan Muthusamy, Qiuhong Zhao, et al.
Leukemia|October 8, 2015
Incidence and description of autoimmune cytopenias during treatment with ibrutinib for chronic lymphocytic leukemiaK A Rogers, A S Ruppert, A Bingman, et al.
Hematological Oncology|May 10, 2024
Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patientsKaitlin Annunzio, Subodh Bhatta, Walter Hanel, et al.
Haematologica|August 30, 2023
Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND studyJohannes Duell, Pau Abrisqueta, Marc Andre, et al.
Blood|March 31, 2010
17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibitionErin Hertlein, Amy J Wagner, Jeffrey Jones, et al.
Pageof 22

Showing results (21-30 of 215) with videos related to

Sort By:
Pageof 22
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|December 28, 2018
Illness Perceptions in Chronic Lymphocytic Leukemia: Testing Leventhal's Self-regulatory ModelTravis D Westbrook, Eleshia J Morrison, Kami J Maddocks, et al.
Transplantation and Cellular Therapy|March 29, 2026
Phase I Trial of Venetoclax and BEAM followed by Autologous Stem Cell Transplant for High-Risk non-Hodgkin LymphomaJoseph E Maakaron, Qiuhong Zhao, Jayalakshmi P Balakrishna, et al.
Haematologica|July 8, 2021
Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib studyPaolo Strati, Sven De Vos, Jia Ruan, et al.
Cancer|December 11, 2019
Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 studyJonathon B Cohen, Lai Wei, Kami J Maddocks, et al.
British Journal of Haematology|December 2, 2017
A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factorKerry A Rogers, Ying Huang, Amy S Ruppert, et al.
Haematologica|May 17, 2020
Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemiaNyla A Heerema, Natarajan Muthusamy, Qiuhong Zhao, et al.
Leukemia|October 8, 2015
Incidence and description of autoimmune cytopenias during treatment with ibrutinib for chronic lymphocytic leukemiaK A Rogers, A S Ruppert, A Bingman, et al.
Hematological Oncology|May 10, 2024
Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patientsKaitlin Annunzio, Subodh Bhatta, Walter Hanel, et al.
Haematologica|August 30, 2023
Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND studyJohannes Duell, Pau Abrisqueta, Marc Andre, et al.
Blood|March 31, 2010
17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibitionErin Hertlein, Amy J Wagner, Jeffrey Jones, et al.
Pageof 22